159 related articles for article (PubMed ID: 24362662)
1. Dermatological disorders in chronic kidney disease with and without maintenance hemodialysis.
Shah A; Hada R; Kayastha BM
JNMA J Nepal Med Assoc; 2013; 52(190):365-71. PubMed ID: 24362662
[TBL] [Abstract][Full Text] [Related]
2. Factors Affecting Dermatological Manifestations in Patients with End Stage Renal Disease.
Anees M; Butt G; Gull S; Nazeer A; Hussain I; Ibrahim M
J Coll Physicians Surg Pak; 2018 Feb; 28(2):98-102. PubMed ID: 29394966
[TBL] [Abstract][Full Text] [Related]
3. Skin changes and dermatological life quality index in chronic kidney disease patients in a tertiary hospital in Southern Nigeria.
Adejumo OA; Madubuko RC; Olokor AB; Aina OT
Niger J Clin Pract; 2019 Feb; 22(2):245-250. PubMed ID: 30729950
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous and mucosal manifestations in patients on maintenance hemodialysis: a study of 101 patients in Sari, Iran.
Hajheydari Z; Makhlough A
Iran J Kidney Dis; 2008 Apr; 2(2):86-90. PubMed ID: 19377214
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous manifestations in hemodialysis patients].
Dahbi N; Hocar O; Akhdari N; Amal S; Bassit N; Fadili W; Laouad I
Nephrol Ther; 2014 Apr; 10(2):101-5. PubMed ID: 24508001
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.
Solak B; Acikgoz SB; Sipahi S; Erdem T
Int Urol Nephrol; 2016 Apr; 48(4):585-91. PubMed ID: 26762886
[TBL] [Abstract][Full Text] [Related]
8. [Dermatological changes in patients receiving long-term hemodialysis].
Lubach D
Hautarzt; 1980 Feb; 31(2):82-5. PubMed ID: 7399899
[TBL] [Abstract][Full Text] [Related]
9. Dermatological manifestations in children with chronic kidney disease: a study from a North Indian tertiary care institute.
Pratyusha K; Dawman L; Vinay K; Tiewsoh K; Sharawat IK
Clin Exp Dermatol; 2021 Oct; 46(7):1270-1276. PubMed ID: 33904201
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis-related pruritus and associated cutaneous manifestations.
Dyachenko P; Shustak A; Rozenman D
Int J Dermatol; 2006 Jun; 45(6):664-7. PubMed ID: 16796623
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous and nail changes in patients of chronic kidney disease: observations in a tertiary care unit from South India.
Koduru S; Delhi N; Parvathina SN; Siva Kumar V
Hemodial Int; 2013 Jul; 17(3):468-70. PubMed ID: 23621562
[No Abstract] [Full Text] [Related]
12. Mucocutaneous manifestations and nail changes in patients with end-stage renal disease on hemodialysis.
Tajbakhsh R; Dehghan M; Azarhoosh R; Haghighi AN; Sadani S; Zadeh SS; Kabootari M; Qorbani M
Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):36-40. PubMed ID: 23354189
[TBL] [Abstract][Full Text] [Related]
13. Pattern of skin and nail changes in chronic renal failure in Nepal: a hospital-based study.
Amatya B; Agrawal S; Dhali T; Sharma S; Pandey SS
J Dermatol; 2008 Mar; 35(3):140-5. PubMed ID: 18346256
[TBL] [Abstract][Full Text] [Related]
14. Skin changes in patients with chronic renal failure.
Falodun O; Ogunbiyi A; Salako B; George AK
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):268-72. PubMed ID: 21422624
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease-associated pruritus in patients undergoing hemodialysis: Xerosis and topical therapy.
Krismi A; Danarti R; Setiabudi IIDPP; Wirohadidjojo YW
Hemodial Int; 2023 Apr; 27(2):91-104. PubMed ID: 36811513
[TBL] [Abstract][Full Text] [Related]
16. Changes in osmol gap in chronic kidney disease: an exploratory study.
Shaikh G; Sehgal R; Sandhu S; Vaddineni S; Fogel J; Rubinstein S
Ren Fail; 2014 Mar; 36(2):198-201. PubMed ID: 24111718
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations in patients with chronic renal failure on hemodialysis.
Udayakumar P; Balasubramanian S; Ramalingam KS; Lakshmi C; Srinivas CR; Mathew AC
Indian J Dermatol Venereol Leprol; 2006; 72(2):119-25. PubMed ID: 16707817
[TBL] [Abstract][Full Text] [Related]
18. Bisphenol A in chronic kidney disease.
Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
[TBL] [Abstract][Full Text] [Related]
19. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease.
Fouque D; Holt S; Guebre-Egziabher F; Nakamura K; Vianey-Saban C; Hadj-Aïssa A; Hoppel CL; Kopple JD
J Ren Nutr; 2006 Apr; 16(2):125-31. PubMed ID: 16567268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
